These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 10415728)

  • 1. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
    Thompson RW; Baxter BT
    Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
    Abdul-Hussien H; Hanemaaijer R; Verheijen JH; van Bockel JH; Geelkerken RH; Lindeman JH
    J Vasc Surg; 2009 Mar; 49(3):741-9. PubMed ID: 19268776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms.
    Curci JA; Mao D; Bohner DG; Allen BT; Rubin BG; Reilly JM; Sicard GA; Thompson RW
    J Vasc Surg; 2000 Feb; 31(2):325-42. PubMed ID: 10664501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.
    Elmore JR; Keister BF; Franklin DP; Youkey JR; Carey DJ
    Ann Vasc Surg; 1998 May; 12(3):221-8. PubMed ID: 9588507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.
    Petrinec D; Liao S; Holmes DR; Reilly JM; Parks WC; Thompson RW
    J Vasc Surg; 1996 Feb; 23(2):336-46. PubMed ID: 8637112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of tetracycline derivatives to suppress the growth of abdominal aortic aneurysms.
    Thompson RW; Liao S; Curci JA
    Adv Dent Res; 1998 Nov; 12(2):159-65. PubMed ID: 9972142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells.
    Liu J; Xiong W; Baca-Regen L; Nagase H; Baxter BT
    J Vasc Surg; 2003 Dec; 38(6):1376-83. PubMed ID: 14681644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms.
    Sho E; Chu J; Sho M; Fernandes B; Judd D; Ganesan P; Kimura H; Dalman RL
    J Vasc Surg; 2004 Jun; 39(6):1312-21. PubMed ID: 15192574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms.
    Patel MI; Melrose J; Ghosh P; Appleberg M
    J Vasc Surg; 1996 Jul; 24(1):82-92. PubMed ID: 8691532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms.
    Davis V; Persidskaia R; Baca-Regen L; Itoh Y; Nagase H; Persidsky Y; Ghorpade A; Baxter BT
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1625-33. PubMed ID: 9763536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines.
    Curci JA; Petrinec D; Liao S; Golub LM; Thompson RW
    J Vasc Surg; 1998 Dec; 28(6):1082-93. PubMed ID: 9845660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
    Castro MM; Rizzi E; Figueiredo-Lopes L; Fernandes K; Bendhack LM; Pitol DL; Gerlach RF; Tanus-Santos JE
    Atherosclerosis; 2008 Jun; 198(2):320-31. PubMed ID: 18054360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908).
    Moore G; Liao S; Curci JA; Starcher BC; Martin RL; Hendricks RT; Chen JJ; Thompson RW
    J Vasc Surg; 1999 Mar; 29(3):522-32. PubMed ID: 10069917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta.
    Tamarina NA; McMillan WD; Shively VP; Pearce WH
    Surgery; 1997 Aug; 122(2):264-71; discussion 271-2. PubMed ID: 9288131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms.
    Bigatel DA; Elmore JR; Carey DJ; Cizmeci-Smith G; Franklin DP; Youkey JR
    J Vasc Surg; 1999 Jan; 29(1):130-8; discussion 138-9. PubMed ID: 9882797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.
    Vinh A; Gaspari TA; Liu HB; Dousha LF; Widdop RE; Dear AE
    J Vasc Res; 2008; 45(2):143-52. PubMed ID: 17957103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm.
    Kazi M; Zhu C; Roy J; Paulsson-Berne G; Hamsten A; Swedenborg J; Hedin U; Eriksson P
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1341-6. PubMed ID: 15845912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal Aortic Aneurysm-Associated MicroRNA-516a-5p Regulates Expressions of Methylenetetrahydrofolate Reductase, Matrix Metalloproteinase-2, and Tissue Inhibitor of Matrix Metalloproteinase-1 in Human Abdominal Aortic Vascular Smooth Muscle Cells.
    Chan CYT; Cheuk BLY; Cheng SWK
    Ann Vasc Surg; 2017 Jul; 42():263-273. PubMed ID: 28288890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of novel limited-spectrum MMP inhibitor XL784 in abdominal aortic aneurysms.
    Ennis T; Jin J; Bartlett S; Arif B; Grapperhaus K; Curci JA
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):417-26. PubMed ID: 22894883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Drugs Effect on Mesenchymal Stem Cells Isolated From Abdominal Aortic Aneurysm.
    Pini R; Ciavarella C; Faggioli G; Gallitto E; Indelicato G; Fenelli C; Mascoli C; Vacirca A; Gargiulo M; Pasquinelli G
    Ann Vasc Surg; 2020 Aug; 67():490-496. PubMed ID: 32173476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.